ライフサイエンスコーパス: with moderate

1 roughout the spinal cord was detected, along with moderate (47%) loss of anterior horn neurons, notab

2 aps activation and repolarization parameters with moderate accuracy.

3 Children with moderate acute malnutrition (MAM) are treated based

4 spiratory distress syndrome, 58% of patients with moderate acute respiratory distress syndrome, and 4

5 In the subgroup of patients with moderate/advanced Parkinson's disease, loss of 11C-

6 inity-based models fail to classify peptides with moderate affinities, DeepLigand discriminates ligan

7 and exchange by cooperatively binding oxygen with moderate affinity.

8 The longevity observed with moderate alcohol consumption may be explained by ot

9 The fecal microbiome in patients with moderate alcoholic hepatitis (MAH) or severe alcoho

10 low anti-VEGF injection frequencies, coupled with moderate anatomic and limited VA improvements, in U

11 Thirty-seven eyes with moderate and advanced POAG, 19 eyes with atrophic N

12 ntially lower lifetime risk for CVD compared with moderate and low CVH, in white and black men and wo

13 performed contralateral resistance training with moderate and low volume for 12 weeks.

14 more, whereas the blood profiles of patients with moderate and severe AD showed gradual increases in

15 DALY effects positively correlated with moderate and severe anaemia prevalence in Asia, the

16 ve impairment over time, especially in those with moderate and severe impairments.

17 We retrospectively evaluated 294 patients with moderate and severe infections.

18 It demonstrated that among those with moderate and severe periodontitis, the chance of ha

19 lity was 56% and 67%, respectively, in those with moderate AS (mean gradient 20.0 to 39.0 mm Hg/peak

20 omplexes for trans-isoprene in the gas phase with moderate association energies.

21 her agreement under RCP 8.5 than simulations with moderate carbon mitigation (i.e., RCP 4.5).

22 Higher proportion of patients with moderate CD (SES-CD scores, 7-15) achieved endoscop

23 er field over a short-term treatment period, with moderate certainty for elemental diets, low certain

24 ge, 0.79-0.99; specificity range, 0.90-0.99) with moderate certainty in the evidence.

25 arge beneficial effects compared to fluoride with moderate certainty of evidence (SMD; 95% CI): potas

26 The USPSTF concludes with moderate certainty that behavioral counseling inter

27 The USPSTF concludes with moderate certainty that behavioral counseling inter

28 The USPSTF concludes with moderate certainty that primary care-feasible behav

29 In adults, the USPSTF concludes with moderate certainty that screening by asking questio

30 review of the evidence, the USPSTF concludes with moderate certainty that screening for AAA in men ag

31 review of the evidence, the USPSTF concludes with moderate certainty that screening for and treatment

32 The USPSTF concludes with moderate certainty that screening for and treatment

33 The USPSTF concludes with moderate certainty that screening for asymptomatic

34 The USPSTF concludes with moderate certainty that screening for HBV infection

35 The USPSTF concludes with moderate certainty that screening for HCV infection

36 The USPSTF concludes with moderate certainty that the harms of screening for

37 assium were beneficial for tactile stimulus, with moderate certainty.

38 fects compared to fluoride (3.93; 0.34-7.53) with moderate certainty; for air stimulus, arginine (2.2

39 addition proceeds through a transition state with moderate charge transfer character.

40 Consecutive patients with <=moderate chronic AR quantified by effective regur

41 t long-term oxygen use in patients with COPD with moderate chronic resting hypoxemia, 3) conditional

42 similar to that observed for HFrEF patients with moderate CKD.

43 subcompartments using typical Hi-C datasets with moderate coverage.

44 ing an early increase in cytokines, patients with moderate COVID-19 displayed a progressive reduction

45 kines and blood-cell phenotyping in patients with moderate COVID-19 who had not received immunomodula

46 Compared to patients with moderate COVID-19, patients with severe COVID-19 ha

47 Specifically, in a regime with moderate densities and a weak polar bias in the ali

48 Here we show that crayfish with moderate densities of symbionts aligned bimodally a

49 l calibrated (Hosmer-Lemeshow P value >0.05) with moderate discrimination (C statistics: 0.65 derivat

50 uded 30 patients with severe and 63 patients with moderate disease (median age, 74 d; range, 9-297 d)

51 In contrast, individuals with moderate disease exhibited delayed responses that u

52 with AD (20 with mild or limited disease, 17 with moderate disease, and 24 with severe disease) and 2

53 vere disease compared with those of patients with moderate disease.

54 reduced fall rates were apparent among those with moderate disease.

55 ndard zone CRAE and CRVE were not associated with moderate DR.

56 broadly impaired item memory in AUD compared with moderate drinkers (p < 0.001), but enhanced associa

57 ing T cell receptors that engage IA(b)-Padi4 with moderate dwell times within a conventional docking

58 knowledge of diabetic retinopathy (p = .03) with moderate effect (partial eta squared eta(2) = .05);

59 rically enriched syn-products (de = 60-99%), with moderate enantiomeric excesses (ee = 43-56%) but di

60 ts can predict mean annual tree growth rates with moderate explanatory power.

61 d organic carbon predicted THg concentration with moderate fidelity, while suspended sediment and wat

62 ai-A-conjugated enamines showed fluorescence with moderate fluorescence quantum yields (Phi(fl)).

63 erocyclic lactone scaffolds in a single step with moderate functional group tolerance and excellent s

64 e (G6PD) enzyme activity and female patients with moderate G6PD enzyme deficiency; all patients had c

65 classified groups had a higher risk compared with moderate group (adjusted hazard ratio 4.95 [2.02-12

66 art Failure Trial) randomized 2,521 patients with moderate heart failure (HF) to amiodarone, placebo

67 albeit for planar samples or nanostructures with moderate height variations.

68 a module of 681 co-expressed genes; 10 genes with moderate-high correlation with ACE2 (r > 0.3, FDR <

69 reatments for primary prevention in patients with moderate-high future risk of developing atheroscler

70 ic, insulin-like peptide in cone-snail venom with moderate human insulin-like bioactivity.

71 ored for organic acids and neutral chemicals with moderate hydrophobicity.

72 eplacing SFAs with PUFAs in healthy subjects with moderate hypercholesterolemia (n = 99).

73 and/or clinical disease failure (BCDF) rate with moderate hypofractionated intensity-modulated radia

74 lation and G(2)-M checkpoint were associated with moderate hypoxia, epithelial-to-mesenchymal transit

75 and BPRS (41 +/- 13) scores were consistent with moderate impairment.

76 rate (WR(peak) ) with 30 s at 50% WR(peak) ) with moderate-intensity constant-load exercise (CLE) at

77 HIT, compared with moderate-intensity continuous training, resulted in

78 with severe keratoconus compared with those with moderate keratoconus.

79 ence that burnout can effectively be reduced with moderate levels of investment, these findings sugge

80 The first two experiments (EXP1-2) were run with moderate levels of O. cf. ovata cell numbers (ca. 1

81 emia (eg, endovascular infections) and those with moderate likelihood when cultures from the primary

82 light near the fiber end into a broad light with moderate local intensity to reduce the degradation

83 In a large national cohort with moderate loss to follow-up, we contrasted racial di

84 of DCD LT were divided into 3 groups: those with moderate macrosteatosis (30%-60%), mild macrosteato

85 Patients with moderate macrosteatosis had a higher rate of postre

86 When utilizing DCD donors with moderate macrosteatosis higher rates of PRS, PNF, p

87 power of more than 10 million at m/q = 1000 with moderate magnetic fields of about 7 T.

88 servation of small skyrmion Hall angles even with moderate magnetisation damping values.

89 nidin in real-world agricultural landscapes, with moderate, natural disease pressure.

90 ith DM without DR, 53 with mild NPDR, and 22 with moderate NPDR.

91 Patients with moderate or greater triscuspid regurgitation, New Y

92 Independent factors associated with moderate or high rating of A MeaSurement Tool to As

93 e to SST in areas in the Asia-Pacific region with moderate or high transmission of malaria.

94 st that programmes combining impact exercise with moderate or high-intensity progressive resistance e

95 within 90 d after PET (P = 0.0369), compared with moderate or mild CFC, coronary flow reserve, other

96 thm should receive beta-blocker therapy even with moderate or moderately severe renal dysfunction.

97 nificantly worse VF progression than sectors with moderate or only 1 observed ODH.

98 Among adults with moderate or severe ARDS, intravenous IFN-beta-1a ad

99 In total, 1,131 patients with moderate or severe AS and complete clinical follow-

100 risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary di

101 Among patients with moderate or severe COPD who did not have an establi

102 ly analysed immune responses in 113 patients with moderate or severe COVID-19.

103 Twenty-eight neonates with moderate or severe HIE treated with TH were include

104 redictor of injury and mortality in neonates with moderate or severe HIE.

105 Among patients with moderate or severe IPF, treatment with oral co-trim

106 We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive

107 In the overall trial population with moderate or severe ischemia, which included 35% of

108 Among patients with moderate or severe LVH treated with TAVR who are al

109 2 months, proportions of HEU and HU children with moderate or severe malnutrition were compared cross

110 In this preliminary study of adults with moderate or severe OSA in whom conventional therapy

111 s of children or teenagers (aged 4-17 years) with moderate or severe PA.

112 Factors associated with moderate or severe parental depression included pre

113 ical trial involving women 21 years or older with moderate or severe stress and urgency urinary incon

114 ith increased odds of survival in casualties with moderate or severe TBI (p<0.0001, OR 2.71, 95% CI 2

115 dic protein to predict prognosis in patients with moderate or severe traumatic brain injury.

116 Stroke patients aged at least 18 years with moderate or severe upper limb functional limitation

117 significantly greater (P < .01) in patients with moderate or severe vorticity (0.73 L/min +/- 0.55)

118 Among interventions with moderate- or high-quality evidence for efficacy com

119 ifidobacterium spp was the only intervention with moderate- or high-quality evidence of reduced all-c

120 , 12, 18, and 24 months), and fewer patients with moderate-or-severe PTS (Villalta scale >=10 or ulce

121 .0%) demonstrated OSA: 150 with mild OSA, 26 with moderate OSA, and 2 with severe OSA.

122 fected son with severe pain, affected mother with moderate pain, and an unaffected father).

123 veloped extensive glomerular injury compared with moderate pathology in allografts with 0.5 hour of c

124 n comparing generalized severe periodontitis with moderate periodontitis and healthy group: oral hypo

125 sy revealed acanthosis and focal lymphocytes with moderate perivascular lymphocyte infiltration.

126 every 4 hours for 24 hours from 10 patients with moderate, persistent asthma and 10 matched, nonalle

127 nd, 2-methyl-8-nitroquinazolin-4(3H)-one (2) with moderate potency (MIC = 312/156 muM).

128 itors revealed that vadadustat inhibits AspH with moderate potency.

129 uality, except for Mealtime Engagement Scale with moderate psychometric quality in assessing mealtime

130 ly small current densities (<500 mA cm(-2) ) with moderate radiance (<400 W sr(-1) m(-2) ).

131 ts with CHADS(2) scores 4 to 6, and patients with moderate renal dysfunction.

132 illions of people, was previously associated with moderate risk of brain tumors and other neoplasms.

133 should be urgently prioritised in countries with moderate risk that might be ill-prepared to detect

134 For datasets with moderate sample size (e.g., nCases = nControls = 30

135 significantly decrease infection costs, even with moderate sampling.

136 sing a Q Exactive orbitrap mass spectrometer with moderate scanning speed (12 Hz) and perform very we

137 Similarly, among infants with moderate SCORAD (15-<40) at enrollment, EIG infants

138 romise in patients who undergo IR procedures with moderate sedation in the United States are poorly u

139 in newly diagnosed MM, which can be screened with moderate sensitivity using cost-effective MFC.

140 to the M. xanthus genome at multiple sites, with moderate sequence specificity; however, its depleti

141 Consecutive patients with >= moderate-severe AR were retrospectively identifi

142 From 2006 to 2017, consecutive patients with >=moderate-severe chronic AR without prior heart su

143 Twelve patients with moderate-severe AR underwent 5 alternate day challe

144 anagement decisions in asymptomatic patients with moderate-severe AS.

145 however, almost half of patients identified with moderate-severe MR are turned down for traditional

146 rade policy was not significantly associated with moderate-severe or severe food insecurity after cov

147 Patients (N=614) with moderate-severe or severe secondary mitral regurgit

148 n), treatment of heart failure (HF) patients with moderate-severe or severe secondary mitral regurgit

149 Forty patients with moderate-severe traumatic brain injury and cognitiv

150 itivity = 92.2%) and was strongly associated with moderate/severe periodontitis after adjusting by so

151 rdiographic outflow gradient (1 mixed lesion with moderate/severe pulmonary valve regurgitation).

152 covered Monoplacophora sister to Cephalopoda with moderate support, both ML and Bayesian inference (B

153 Consecutive patients with >= moderate to severe AR were retrospectively ident

154 llylic alcohols in modest to high yields and with moderate to excellent diastereoselectivity.

155 ields, partially as single diastereomers and with moderate to excellent enantioselectivity.

156 orresponding C-glycosides in up to 95% yield with moderate to excellent stereoselectivities.

157 highly substituted quinolines were obtained with moderate to excellent yields (up to 96%).

158 ctionalized allylthio-containing pyrazolones with moderate to excellent yields.

159 m images from unenhanced multiparametric MRI with moderate to high accuracy.

160 23 reversibly bound to the respective H(2)Rs with moderate to high affinity (human/guinea pig/mouse K

161 d that vaccination with immunogens that bind with moderate to high affinity to bnAb B cell precursors

162 arge beneficial effects compared to fluoride with moderate to high certainty.

163 uous tertiary stereocenters in a single step with moderate to high levels of diastereocontrol and exc

164 and for confirmatory testing in individuals with moderate to high pretest probability of SARS-CoV-2

165 t general synthesis of dibenzo[a,c]acridines with moderate to high yields.

166 614 patients with symptomatic heart failure with moderate to severe (3+) or severe (4+) secondary MR

167 that adults who receive kidneys from donors with moderate to severe acute kidney injury (AKI) have s

168 ention costing less than $51,328 per patient with moderate to severe acute respiratory distress syndr

169 Patients with moderate to severe acute respiratory distress syndr

170 in skin transcriptome data from 57 patients with moderate to severe AD and 31 healthy controls.

171 ind, placebo-controlled study of 54 patients with moderate to severe AD randomized (1:1) and treated

172 e adopting the practice of accepting kidneys with moderate to severe AKI in pediatric kidney transpla

173 We recruited ventilated patients with moderate to severe ARDS (ratio of partial pressure

174 2015-December 2017) that included 301 adults with moderate to severe ARDS according to the Berlin def

175 Among patients with moderate to severe ARDS, PES-guided PEEP, compared

176 center randomized controlled trial in adults with moderate to severe ARDS.

177 ety after administration of MSCs to patients with moderate to severe ARDS.

178 ose of intravenous MSCs was safe in patients with moderate to severe ARDS.

179 Control and Prevention advises that patients with moderate to severe asthma belong to a high-risk gro

180 therwise healthy children aged 2 to 17 years with moderate to severe asthma defined by a Pediatric Re

181 ght to assess the safety of LAIV in children with moderate to severe asthma, and in preschool childre

182 cacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis.

183 kinase 1 inhibitor upadacitinib in patients with moderate to severe atopic dermatitis.

184 cted from June 2008 to June 2018 in patients with moderate to severe benign prostatic hyperplasia-rel

185 In adults with moderate to severe CATD receiving cholinesterase in

186 rmed a double-blind, phase 2 trial in adults with moderate to severe CD and inadequate response or in

187 ple confounders, we studied 2738 individuals with moderate to severe CKD participating in the multice

188 In a cohort of individuals with moderate to severe CKD, we observed steep declines

189 ort course of methylprednisolone in patients with moderate to severe COVID-19 reduced escalation of c

190 of early corticosteroid therapy in patients with moderate to severe COVID-19.

191 ransmission exists through tears in patients with moderate to severe COVID-19.

192 CT02925117; ongoing, not recruiting), adults with moderate to severe disease and inadequate control b

193 good accuracy for identifying case children with moderate to severe fibrosis (area under the receive

194 nriched in the fecal microbiomes of patients with moderate to severe fibrosis (P < .001).

195 Stroke patients presented with moderate to severe hand motor deficits.

196 xtract in adolescents (aged >=12) and adults with moderate to severe HDM-induced allergic rhinitis.

197 Twenty-one individuals with moderate to severe hearing loss were recruited.

198 -term neurodevelopmental outcome of neonates with moderate to severe HIE.

199 Both of these variants were segregating with moderate to severe ID, microcephaly, and various fa

200 Among 70 grafts with moderate to severe IRI, 42.9% of grafts developed E

201 rebral microhemorrhage is common in patients with moderate to severe ITP.

202 , we validated the array by testing patients with moderate to severe ME/CFS patients and healthy cont

203 The study enrolled adults with moderate to severe nonpsychotic depression and a hi

204 Similarly, patients with moderate to severe NPDR had a higher risk of each o

205 Among patients with moderate to severe OA of the knee or hip and inadeq

206 treatment of daytime sleepiness in patients with moderate to severe obstructive sleep apnea refusing

207 tructured interviews with patients diagnosed with moderate to severe open-angle glaucoma, focusing on

208 irway pressure (CPAP) withdrawal in patients with moderate to severe OSA.

209 th and without EMD in 51 patients presenting with moderate to severe periodontitis (PPD = 5 to 8 mm)

210 bo-controlled, exploratory trial in patients with moderate to severe plaque psoriasis without clinica

211 are potentially life-threatening in patients with moderate to severe primary immunodeficiency disorde

212 be deferred even longer in female recipients with moderate to severe proteinuria, uncontrolled hypert

213 Patients with moderate to severe pruritus (>=5 of 10 on visual an

214 ticipants included 68 white and black adults with moderate to severe psoriasis who had and had not re

215 ighly effective, and recommended in patients with moderate to severe SSR and in patients with SSR con

216 very well in predicting COVID-19 in patients with moderate to severe symptoms and has substantial int

217 has been primarily restricted to individuals with moderate to severe symptoms due to limited test ava

218 The system is meant to be used in patients with moderate to severe symptoms of COVID-19.

219 Among patients with moderate to severe TBI, out-of-hospital tranexamic

220 Focused questions in adult outpatients with moderate to severe UC included: (1) overall and com

221 imal management of outpatients or inpatients with moderate to severe UC often requires the use of imm

222 ed describing the indirect costs in patients with moderate to severe UC.

223 medical centers between March and April 2020 with moderate to severe upper respiratory symptoms suspi

224 NAFLD had a significant association only with moderate to severe WMH (OR: 1.64, 95% CI: 1.10-2.42

225 Repeat echocardiogram showed an enlarged LV with moderate to severely depressed LV function (EF, 28%

226 ystems undergo the iodine-catalyzed reaction with moderate to very good yields in both polar and apol

227 A total of 3630 patients with moderate to very severe COPD and either a history o

228 unburned forests to 11 in pyrodiverse areas with moderate- to high-severity.

229 es, furnishing sp(2) -sp(3) coupled products with moderate-to-good regioselectivity.

230 ate that L-whirlin binds to PCDH15 and CDH23 with moderate-to-high affinities in vitro.

231 incidence of mosaicism in families with PIDs with moderate-to-high suspicion of gene mosaicism (n = 3

232 ty of VT-1161 versus fluconazole in subjects with moderate-to-severe acute VVC.

233 nonlesional tissues and blood from patients with moderate-to-severe AD (n = 246) and age-matched con

234 from lesional and nonlesional skin of adults with moderate-to-severe AD and psoriasis.

235 and molecular biomarker profile of patients with moderate-to-severe AD and to correlate changes in b

236 Biopsy specimens from 59 patients with moderate-to-severe AD before and 30 patients 12 wee

237 sional and nonlesional skin from 59 patients with moderate-to-severe AD treated with anti-IL-22 (feza

238 cebo, with topical corticosteroids in adults with moderate-to-severe AD, severe pruritus, and inadequ

239 fficacy and safety of tralokinumab in adults with moderate-to-severe AD.

240 87 (30 mg) once-daily oral therapy in adults with moderate-to-severe AD.

241 rolled trial with 634 subjects (12-65 years) with moderate-to-severe ARC despite use of symptom-relie

242 We randomly assigned patients with moderate-to-severe ARDS (defined by a ratio of the

243 -matched external comparator cohort of women with moderate-to-severe asthma (n = 1153), termed the Qu

244 data from bronchial biopsies of 81 patients with moderate-to-severe asthma of the U-BIOPRED cohort.

245 nome-wide significant signals of association with moderate-to-severe asthma, including several signal

246 o identity novel genetic variants associated with moderate-to-severe asthma, see whether previously i

247 al (JADE MONO-1), patients (aged >=12 years) with moderate-to-severe atopic dermatitis (Investigator

248 a antibody used in the treatment of patients with moderate-to-severe atopic dermatitis (msAD).

249 , was effective and well tolerated in adults with moderate-to-severe atopic dermatitis in a phase 2b

250 and well tolerated in adolescents and adults with moderate-to-severe atopic dermatitis.

251 itinib monotherapy in adolescents and adults with moderate-to-severe atopic dermatitis.

252 er trial was conducted in 406 adult patients with moderate-to-severe birch pollen-induced allergic rh

253 Patients (n = 323) 18 years and older with moderate-to-severe congestion and NPs were randomiz

254 subjects with severe asthma and 78 subjects with moderate-to-severe COPD in a prospective single cen

255 cally ventilated patients (aged 40-75 years) with moderate-to-severe COVID-19 ARDS were included.

256 Patients with moderate-to-severe COVID-19 pneumonia are likely to

257 illness to 10-21 day of illness in patients with moderate-to-severe COVID-19, but not in those with

258 eks of treatment, the proportion of patients with moderate-to-severe CRSwNP (VAS > 3-10) decreased fr

259 ery beyond decompressive surgery in patients with moderate-to-severe degenerative cervical myelopathy

260 Patients with moderate-to-severe degenerative cervical myelopathy

261 Children with moderate-to-severe diarrhoea and age-matched and co

262 s, although Shigella spp remained associated with moderate-to-severe diarrhoea in both nutritional gr

263 12-23 months also had a stronger association with moderate-to-severe diarrhoea in children with acute

264 us suggested they had a stronger association with moderate-to-severe diarrhoea than other pathogens a

265 92 (64%) of 144 children with moderate-to-severe diarrhoea who died had acute mal

266 Among children with moderate-to-severe diarrhoea, Cox proportional haza

267 itis (AD) are largely restricted to patients with moderate-to-severe disease.

268 In influenza patients with moderate-to-severe diseases, we uncover a complex l

269 ), a multicenter clinical trial for patients with moderate-to-severe DR treated with AKB-9778 and fol

270 nt predictor of the need for TPK in patients with moderate-to-severe filamentous fungal keratitis.

271 f two dose cohorts of bermekimab in patients with moderate-to-severe HS who are naive to or have fail

272 CI, 0.90 to 1.63), and admission to the NICU with moderate-to-severe hypoxic-ischemic encephalopathy

273 n to the neonatal intensive care unit (NICU) with moderate-to-severe hypoxic-ischemic encephalopathy

274 Thirteen infants (69% male) >=36 weeks with moderate-to-severe NE were enrolled.

275 )/CD8(+) T cells in the blood of 19 patients with moderate-to-severe nonsegmental/generalized vitilig

276 2014 and March 2018, and focused on patients with moderate-to-severe ocular irAEs following anti-PD-(

277 l Regurgitation) trial, 614 patients with HF with moderate-to-severe or severe SMR were randomized to

278 41, an oral TYK2/Jak1 inhibitor, in patients with moderate-to-severe plaque psoriasis (NCT02969018).

279 esional skin biopsy samples from 81 patients with moderate-to-severe plaque psoriasis participating i

280 umab in providing skin clearance in patients with moderate-to-severe plaque psoriasis.

281 of risankizumab with adalimumab in patients with moderate-to-severe plaque psoriasis.

282 lly effective and well tolerated in patients with moderate-to-severe plaque psoriasis.

283 eek 8, as compared with placebo, in patients with moderate-to-severe prurigo nodularis and severe pru

284 led, double-blind treatment period, patients with moderate-to-severe psoriasis received secukinumab f

285 Patients (n = 30) with moderate-to-severe psoriasis were randomized to onc

286 n this international case series of patients with moderate-to-severe psoriasis, biologic use was asso

287 glucose metabolism in the blood of patients with moderate-to-severe psoriasis.

288 ations are decreased in very preterm infants with moderate-to-severe structural cerebellar injury.

289 tcome in this prospective cohort of patients with moderate-to-severe traumatic brain injury.

290 Among patients with moderate-to-severe UC in the US and EU5, active dis

291 pha(4)beta(7) antibody abrilumab in patients with moderate-to-severe ulcerative colitis despite treat

292 al response, and mucosal healing in patients with moderate-to-severe ulcerative colitis.

293 ducing and maintaining remission in patients with moderate-to-severe ulcerative colitis.

294 rikizumab improves lung function in patients with moderate-to-severe uncontrolled asthma, but its eff

295 Forced vital capacity (FVC) was associated with moderate-to-vigorous physical activity (MVPA; accel

296 istries enrolling medically managed patients with >= moderate tricuspid regurgitation in Europe and N

297 associated with increased mortality compared with moderate UF(NET) rates.

298 clinical and immunological outcomes observed with moderate versus heavy alcohol drinking.

299 6% [2.6%-22.6%]; black women, 0.0%) compared with moderate (white women, 16.6% [13.0%-20.2%]; black w

300 ers, again in high selectivity (up to 99:1), with moderate yields.